Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00450541 · ClinicalTrials.gov registry record
Fatigue Experience in Cancer Patients
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 73
- Enrollment target
NCT00450541: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00450541 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 73 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00450541 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 73 participants
- Enrollment target
Study Summary
The goal of this research study is to learn what it is like when a patient with cancer has fatigue, as well as how these patients define fatigue. Researchers want to use this information to create questionnaires that may more accurately measure fatigue and its effects in patients with cancer.
Interventions
- BEHAVIORAL Questionnaire
- BEHAVIORAL Interview
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2007-03 |
| Est. Completion | 2010-04 |
What the finished NCT00450541 record still lists
NCT00450541 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 73 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Questionnaire is the first listed.
NCT00450541 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00450541 about?
NCT00450541 is a clinical study titled "Fatigue Experience in Cancer Patients". The goal of this research study is to learn what it is like when a patient with cancer has fatigue, as well as how these patients define fatigue. Researchers want to use this information to create questionnaires that may more accurately measure fatigue and its effects in patients with cancer.
What is the current status of trial NCT00450541?
This trial is currently completed. The enrollment target is 73 participants. The study started on 2007-03. Estimated completion is 2010-04.
What interventions are being tested in trial NCT00450541?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Interview (BEHAVIORAL).
Who is sponsoring clinical trial NCT00450541?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03661307 · 73 participants · Phase 1
Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
- NCT05386108 · 73 participants · Phase 1
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- NCT05961592 · 73 participants · Phase 1
R-2487 in Patients With Rheumatoid Arthritis
- NCT06150664 · 73 participants · Phase 1
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia